Abbott Laboratories, a global healthcare giant, develops and markets a broad range of medical devices, diagnostics, branded generic medicines, and nutritional products. Its strong focus on innovation ...

Less than five years on from when ... to license it's novel weight-loss and diabetes drug UBT251 to the rest of the world. United will keep the rights to market the medication in China, Hong ...

The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs ... includes a 35-year revenue ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an additional 38% considered overweight. This epidemic not only impacts individual ...

Small-molecule drugs are simpler in structure and made up of fewer atoms than biologics, usually having a molecular weight ... German market is expected to increase at a CAGR of 10.69%, indicating ...

The ‘miracle’ weight ... market for these drugs is valued at ₹576 crore as of February 2025. It has almost quadrupled in the past five years, expanding at a compound annual growth rate ...

Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market ... watched of the year, as they bring ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...